- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BioChaperone® insulin lispro
Total 515 results
-
WockhardtWithdrawn
-
Kaplan Medical CenterUnknown
-
Medical University of ViennaCompleted
-
AdociaTonghua Dongbao Pharmaceutical Co.,LtdCompleted
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
GeropharmCompletedClamp StudyRussian Federation
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Canada, Hungary, Spain, United States, Australia, Puerto Rico, Poland, Belgium, Denmark, Brazil, Mexico, Greece, Argentina, Taiwan, Sweden, Russian Federation
-
Medical University of WarsawCompletedDiabetes Mellitus, Type 1Poland
-
SanofiCompleted
-
SanofiCompletedType 1 Diabetes MellitusJapan, Spain, Germany, United States, France, Hungary, Poland, Russian Federation
-
Sun Yat-sen UniversityEli Lilly and Company; Ministry of Health, China; Amylin Pharmaceuticals, LLC.CompletedDiabetes Mellitus, Type 2 | Newly DiagnosedChina
-
Medical University of GrazCompletedDiabetes, Type IAustria
-
Medical University of WarsawNot yet recruitingDiabetes Mellitus, Type 1
-
Centre Hospitalier Universitaire de BesanconEli Lilly and Company; AstraZenecaCompleted
-
AdociaTonghua Dongbao Pharmaceutical Co.,LtdCompleted
-
Eli Lilly and CompanyCompleted
-
Rush University Medical CenterWithdrawn
-
Emory UniversityCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Korea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, Algeria, Argentina, Bangladesh, China, Egypt, India, Indonesia, Iran, Islamic Republic of, Jordan, Korea, Republic of, Libyan Arab Jamahiriya, Malaysia, Mexico, Morocco, Pakistan, Philippines, Russian Federation and more
-
GeropharmCompletedBioequivalence | Therapeutic EquivalencyRussian Federation
-
AdociaTonghua Dongbao Pharmaceutical Co.,LtdCompleted
-
Eli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2
-
Eli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 1
-
Novo Nordisk A/SCompletedObservational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes (INTENSIV)Diabetes Mellitus, Type 2 | DiabetesAustria
-
Kenneth MaddenWithdrawnDiabetes | Sarcopenia | Hypotension, OrthostaticCanada
-
BiodelCompletedDiabetes MellitusUnited States
-
Riverside University Health System Medical CenterTerminated
-
Centre for Addiction and Mental HealthRecruitingHealthy | SchizophreniaCanada
-
Eli Lilly and CompanyNot yet recruitingHealthy | Type 1 Diabetes MellitusGermany
-
Global Infusion and Aspiration Systems, LLCUnknownDiabetes Mellitus | Metabolic IntegrityUnited States
-
Assaf-Harofeh Medical CenterTerminated
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSlovenia
-
Emory UniversityCompletedDiabetes Mellitus | Type 1 DiabetesUnited States
-
Nanjing First Hospital, Nanjing Medical UniversityCompletedDiabetes Mellitus, Type 2China
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Heidelberg UniversityUnknown
-
Julphar Gulf Pharmaceutical IndustriesProfil Institut für Stoffwechselforschung GmbHCompleted
-
SanofiCompleted
-
Eli Lilly and CompanyCompletedHealthy VolunteersSingapore
-
PfizerCompletedDiabetes MellitusUnited States, Puerto Rico
-
Halozyme TherapeuticsCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesNorway, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTunisia
-
Centre for Addiction and Mental HealthRecruitingDepression | Major Depressive DisorderCanada
-
BiodelCompletedType 1 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Philippines
-
University of Campania "Luigi Vanvitelli"Completed